Sweden
· Delayed Price · Currency is SEK Devyser Diagnostics AB Statistics
Total Valuation
Devyser Diagnostics AB has a market cap or net worth of SEK 1.87 billion. The enterprise value is 1.73 billion.
| Market Cap | 1.87B |
| Enterprise Value | 1.73B |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Devyser Diagnostics AB has 16.48 million shares outstanding. The number of shares has decreased by -2.82% in one year.
| Shares Outstanding | 16.48M |
| Shares Change (YoY) | -2.82% |
| Shares Change (QoQ) | +2.97% |
| Owned by Insiders (%) | 43.14% |
| Owned by Institutions (%) | 39.39% |
| Float | 9.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.41 |
| PB Ratio | 5.08 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.01 |
| EV / Sales | 8.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -20.95 |
Financial Position
The company has a current ratio of 4.40, with a Debt / Equity ratio of 17.61.
| Current Ratio | 4.40 |
| Quick Ratio | 3.73 |
| Debt / Equity | 17.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.78 |
| Interest Coverage | -28.00 |
Financial Efficiency
Return on equity (ROE) is -14.11% and return on invested capital (ROIC) is -8.11%.
| Return on Equity (ROE) | -14.11% |
| Return on Assets (ROA) | -7.23% |
| Return on Capital (ROIC) | -8.11% |
| Revenue Per Employee | 1.54M |
| Profits Per Employee | -426,772 |
| Employee Count | 118 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.48% in the last 52 weeks. The beta is 0.77, so Devyser Diagnostics AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +55.48% |
| 50-Day Moving Average | 110.01 |
| 200-Day Moving Average | 95.69 |
| Relative Strength Index (RSI) | 60.76 |
| Average Volume (20 Days) | 27,689 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Devyser Diagnostics AB had revenue of SEK 196.10 million and -54.20 million in losses. Loss per share was -3.33.
| Revenue | 196.10M |
| Gross Profit | 163.00M |
| Operating Income | -58.80M |
| Pretax Income | -54.90M |
| Net Income | -54.20M |
| EBITDA | -48.40M |
| EBIT | -58.80M |
| Loss Per Share | -3.33 |
Balance Sheet
The company has 201.00 million in cash and 64.80 million in debt, giving a net cash position of 136.20 million or 8.26 per share.
| Cash & Cash Equivalents | 201.00M |
| Total Debt | 64.80M |
| Net Cash | 136.20M |
| Net Cash Per Share | 8.26 |
| Equity (Book Value) | 367.90M |
| Book Value Per Share | 22.35 |
| Working Capital | 228.00M |
Cash Flow
In the last 12 months, operating cash flow was -60.10 million and capital expenditures -22.70 million, giving a free cash flow of -82.80 million.
| Operating Cash Flow | -60.10M |
| Capital Expenditures | -22.70M |
| Free Cash Flow | -82.80M |
| FCF Per Share | -5.02 |
Margins
Gross margin is 83.12%, with operating and profit margins of -29.98% and -27.64%.
| Gross Margin | 83.12% |
| Operating Margin | -29.98% |
| Pretax Margin | -28.00% |
| Profit Margin | -27.64% |
| EBITDA Margin | -24.68% |
| EBIT Margin | -29.98% |
| FCF Margin | -42.22% |
Dividends & Yields
Devyser Diagnostics AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.82% |
| Shareholder Yield | 2.82% |
| Earnings Yield | -2.94% |
| FCF Yield | -4.43% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |